PMD - Psychemedics Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
21.07
+0.10 (+0.48%)
At close: 3:58PM EST
Stock chart is not supported by your current browser
Previous Close20.97
Open21.13
Bid0.00 x 0
Ask0.00 x 0
Day's Range20.94 - 21.13
52 Week Range15.99 - 27.99
Volume1,654
Avg. Volume14,513
Market Cap115.717M
Beta0.79
PE Ratio (TTM)19.02
EPS (TTM)1.11
Earnings DateFeb 5, 2018 - Feb 9, 2018
Forward Dividend & Yield0.60 (2.86%)
Ex-Dividend Date2017-11-03
1y Target Est32.00
Trade prices are not sourced from all markets
  • 6 Cheap Stocks With a High Dividend Yield
    GuruFocus.com2 months ago

    6 Cheap Stocks With a High Dividend Yield

    Companies with negative stock momentum

  • Capital Cube3 months ago

    ETFs with exposure to Psychemedics Corp. : November 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Psychemedics Corp. Here are 5 ETFs with the largest exposure to PMD-US. Comparing the performance and risk of Psychemedics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?
    Simply Wall St.4 months ago

    Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?

    Investors who want to cash in on Psychemedics Corporation’s (NASDAQ:PMD) upcoming dividend of $0.15 per share have only 3 days left to buy the shares before its ex-dividend date, 03Read More...

  • Capital Cube4 months ago

    ETFs with exposure to Psychemedics Corp. : October 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Psychemedics Corp. Here are 5 ETFs with the largest exposure to PMD-US. Comparing the performance and risk of Psychemedics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017
    Capital Cube4 months ago

    Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017

    Categories: Yahoo FinanceGet free summary analysis Psychemedics Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Psychemedics Corp. – NeoGenomics, Inc., Enzo Biochem, Inc., Quest Diagnostics Incorporated and Laboratory Corporation of America Holdings (NEO-US, ENZ-US, DGX-US and LH-US) that have also reported for this period. ... Read more (Read more...)

  • PR Newswire4 months ago

    Psychemedics Corporation Announces Q3 Earnings

    DECLARES 85TH CONSECUTIVE QUARTERLY DIVIDEND ACTON, Mass. , Oct. 24, 2017 /PRNewswire/ -- Psychemedics Corporation (NASDAQ: PMD) today announced third quarter financial results for the period ended September ...

  • Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?
    Simply Wall St.5 months ago

    Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?

    Psychemedics Corporation (NASDAQ:PMD) trades with a trailing P/E of 13.6x, which is lower than the industry average of 21.5x. While PMD might seem like an attractive stock to buy, itRead More...

  • PR Newswire5 months ago

    Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test

    ACTON, Mass., Sept. 26, 2017 /PRNewswire/ -- Psychemedics Corporation (PMD), hair testing pioneer and global leader for over thirty years, announced the launch of its FDA-Cleared Benzodiazepines hair test.  The test detects numerous Benzodiazepines, including Xanax®, Valium®, and Ativan®, and is available as a stand-alone test or as an option on Psychemedics' standard drug panels. The abuse of prescription Benzodiazepines has grown at an alarming rate in the United States, contributing to thousands of emergency room visits and overdose deaths each year. It is important to note that Benzodiazepines can prove deadly when combined with other depressants, including alcohol.  This significantly increases the danger of Benzodiazepine abuse.

  • Capital Cube5 months ago

    ETFs with exposure to Psychemedics Corp. : September 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Psychemedics Corp. Here are 5 ETFs with the largest exposure to PMD-US. Comparing the performance and risk of Psychemedics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • PR Newswire6 months ago

    Psychemedics Corporation Launches Synthetic Cannabinoids Hair Test

    ACTON, Mass., Aug. 22, 2017 /PRNewswire/ -- Psychemedics Corporation (PMD), hair testing pioneer and global scientific leader for over thirty years, announced the launch of its Synthetic Cannabinoids test – a hair test that looks for the compounds found in commonly-abused products such as K2, Spice and Blaze. Synthetic Cannabinoids are often marketed as a "legal high" alternative to marijuana, and are commonly sold as incense in retail stores, head shops and on the internet. The Psychemedics test will be continually updated to address changes in the Synthetic Cannabinoids market, adding additional compounds to the test as they are identified or become prevalent as reported by the scientific, law enforcement and regulatory communities.

  • Capital Cube6 months ago

    ETFs with exposure to Psychemedics Corp. : August 21, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Psychemedics Corp. Here are 5 ETFs with the largest exposure to PMD-US. Comparing the performance and risk of Psychemedics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • PR Newswire6 months ago

    Psychemedics Corporation - First Lab Approved For Hair Testing In Iowa

    Psychemedics was instrumental in getting the law changed to include hair, which has a much longer look-back period than other matrices.  Now, less than one month after the law went into effect, the Iowa Department of Public Health has issued a letter approving Psychemedics to conduct private sector pre-employment drug testing using hair.

  • Psychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017
    Capital Cube6 months ago

    Psychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017

    Categories: Yahoo FinanceGet free summary analysis Psychemedics Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Psychemedics Corp. – NeoGenomics, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, RadNet, Inc. and CombiMatrix Corporation (NEO-US, LH-US, DGX-US, RDNT-US and CBMX-US) that have also reported for ... Read more (Read more...)

  • Associated Press7 months ago

    Psychemedics posts 2Q profit

    The Acton, Massachusetts-based company said it had net income of 16 cents per share. The drug testing company posted revenue of $9.7 million in the period. Psychemedics shares have climbed almost 5 percent ...

  • PR Newswire7 months ago

    Psychemedics Corporation Announces Q2 Earnings

    DECLARES 84th CONSECUTIVE QUARTERLY DIVIDEND ACTON, Mass. , Aug. 2, 2017 /PRNewswire/ -- Psychemedics Corporation (NASDAQ: PMD) today announced second quarter financial results for the period ended June ...

  • Capital Cube8 months ago

    ETFs with exposure to Psychemedics Corp. : June 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Psychemedics Corp. Here are 5 ETFs with the largest exposure to PMD-US. Comparing the performance and risk of Psychemedics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Psychemedics Corp. :PMD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017
    Capital Cube9 months ago

    Psychemedics Corp. :PMD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Psychemedics Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Psychemedics Corp. – NeoGenomics, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, RadNet, Inc., Trovagene, Inc., CombiMatrix Corporation and Interleukin Genetics, Inc. (NEO-US, LH-US, DGX-US, RDNT-US, TROV-US, CBMX-US ... Read more (Read more...)

  • Associated Press10 months ago

    Psychemedics posts 1Q profit

    On a per-share basis, the Acton, Massachusetts-based company said it had profit of 27 cents. The drug testing company posted revenue of $10.2 million in the period. Psychemedics shares have decreased 16 ...

  • PR Newswire10 months ago

    Psychemedics Corporation Announces Record Q1 Revenues And Earnings

    ACTON, Mass., April 25, 2017 /PRNewswire/ -- Psychemedics Corporation (NASDAQ: PMD) today announced first quarter financial results for the period ended March 31, 2017.  The Company also announced a quarterly ...

  • Accesswire11 months ago

    DEADLINE TODAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm

    IRVINE, CA / ACCESSWIRE / April 3, 2017 / Khang & Khang LLP (the "Firm") announces a class action lawsuit against Psychemedics Corporation ("Psychemedics" or the "Company") ...

  • Accesswire11 months ago

    FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017

    NEW YORK, NY / ACCESSWIRE / April 3, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Psychemedics Corporation ("Psychemedics" or ...

  • Accesswire11 months ago

    MONDAY DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Reminds Investors with Losses to Contact the Firm

    LOS ANGELES, CA / ACCESSWIRE / March 31, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Psychemedics Corporation ("Psychemedics" or the "Company") ...

  • Accesswire11 months ago

    UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation -- Sets Lead Plaintiff Deadline of April 3, 2017 -- PMD

    NEW YORK, NY / ACCESSWIRE / March 31, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Psychemedics Corporation ...